ERH Gene and Its Role in Cancer Cells
Overview
Authors
Affiliations
Cancer is a major public health problem worldwide. Studies on oncogenes and tumor-targeted therapies have become an important part of cancer treatment development. In this review, we summarize and systematically introduce the gene enhancer of rudimentary homolog (ERH), which encodes a highly conserved small molecule protein. ERH mainly exists as a protein partner in human cells. It is involved in pyrimidine metabolism and protein complexes, acts as a transcriptional repressor, and participates in cell cycle regulation. Moreover, it is involved in DNA damage repair, mRNA splicing, the process of microRNA hairpins as well as erythroid differentiation. There are many related studies on the role of ERH in cancer cells; however, there are none on tumor-targeted therapeutic drugs or related therapies based on the expression of ERH. This study will provide possible directions for oncologists to further their research studies in this field.
Unveiling as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis.
Chang C, Chen L, Chen Y, Huang C, Yu C, Lin V Biomedicines. 2025; 13(1).
PMID: 39857609 PMC: 11760481. DOI: 10.3390/biomedicines13010025.
Large-scale map of RNA-binding protein interactomes across the mRNA life cycle.
Street L, Rothamel K, Brannan K, Jin W, Bokor B, Dong K Mol Cell. 2024; 84(19):3790-3809.e8.
PMID: 39303721 PMC: 11530141. DOI: 10.1016/j.molcel.2024.08.030.
Wang J, Dou P, Sun Y, Zheng J, Wu G, Liu H Front Genet. 2024; 15:1406150.
PMID: 39156959 PMC: 11327069. DOI: 10.3389/fgene.2024.1406150.
Saei A, Lundin A, Lyu H, Gharibi H, Luo H, Teppo J Adv Sci (Weinh). 2024; 11(38):e2401502.
PMID: 39120068 PMC: 11481203. DOI: 10.1002/advs.202401502.
Tsai Y, Wu K, Huang Y, Wu Y, Chang C, Chang Y Mol Med Rep. 2023; 29(1).
PMID: 37997813 PMC: 10704564. DOI: 10.3892/mmr.2023.13132.